🡄 back

Esphera SynBio
Developing a platform technology for the generation of designer exosomes in vivo or ex vivo

Esphera’s platform technology generates exosomes that deliver defined payloads to targeted cells in the body.

The technology targets several kinds of cells, including tumour cells and immune cells, and deliver a variety of therapeutic payloads, including enzymes and RNAs.

It is designed to enhance existing immunotherapy and vaccine technologies and aid in gene therapy, enzyme replacement therapy and cancer immunotherapy.

Fast Facts
Contact Email: [email protected]
Are you hoping to connect with this partner? Fill out our form below and we can reach out to you to find the best way to connect you.